Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
To study the pharmacokinetic properties, safety and viral resistance pattern of the
combination of tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant
women and their newborns, with a view to prevention of mother-to-child transmission (PMTCT)
of HIV-1 in Africa and Asia.
Phase:
Phase 2
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Collaborators:
European and Developing Countries Clinical Trials Partnership (EDCTP) Gilead Sciences